ESC 365 - Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

ESC Premium Access

Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

Session: Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Topic: Clinical

Speaker: Doctor B. Gersh (Rochester, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)

8 presentations

0 follower

4 more presentations in this session

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)

How should we manage chronic coronary syndromes after the ISCHEMIA trial?

Speaker: Doctor F. Otsuka (Suita, JP)

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

Access the full session

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Speakers: Doctor B. Gersh, Assistant Professor S. Kohsaka, Doctor F. Otsuka

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources